Artificial intelligence (AI) is making its way into virtually every corner of the health care industry, and pharmacy benefit managers are no exception.
Total Pharmacy
Latest News
Total Pharmacy Podcasts
All News
Advertisement
Independent pharmacies can profit from immunizations, boosting loyalty and OTC sales with smart vaccine purchasing and efficient workflows.
Sponsored Content
In a shifting environment, pharmacy success is no longer just about scale but about earning patient trust through consistency and effectively managing affordability.
Sponsored Content
Pharmacy reimbursement stability is built on transparency, financial visibility, and an understanding of upcoming industry shifts.
Experts explore artificial intelligence in PBM-pharmacy relationships and how the technology may impact sustainability.
As PBM-pharmacy relationships evolve in real time, staying proactive when a PBM audit comes through could be the difference between thriving and losing essential business.
Through transformational, authentic, servant, and distributed models, researchers explore the impact of leadership on the pharmacy workforce.
In part 2, Harini Bupathi, Esq, dives deeper into PBMs’ goals behind pharmacy audits and how that could all change with recent reform measures.
As health care spending and polypharmacy increase, researchers are exploring new ways to deprescribe medications, looking to pharmacists to fill in a gap.
Sponsored Content
Community pharmacies have become one of the most accessible points of care for patients, especially in rural and underserved communities.
Advertisement
Harini Bupathi, Esq, discusses the basis of PBM audits, why they exist, and how pharmacies can anticipate them.
Independent pharmacies combat daily drug shortages with smarter inventory monitoring and diversified suppliers.
With social determinants of health impacting patient outcomes, researchers assess the viability of community pharmacy partnerships for addressing atrial fibrillation.
In a recent PSG-sponsored webinar, experts present on the growing push toward new-wave pharmacy benefit managers models in pharmacy benefits design.
As clinical roles expand, the need for robust pharmacy infrastructure to streamline workflows and ensure medication access has never been more critical.
This episode explores the true price of commitment to a dream or vision, explaining how anything less than full dedication can lead to failure and why small wins are essential for perseverance.
With insights from executives working around the clock to advance the pharmacy profession, our experts predicted what the landscape will look like following the Consolidated Appropriations Act of 2026.
Featuring pharmacist and entrepreneur Sam Maddula, PharmD, this episode explores some key legislative and regulatory insights regarding owning and operating a pharmacy business.
Represented by Frier Levitt, multiple hospital systems filed lawsuits on May 21, 2026, targeting a variety of entities existing under CVS Health.
This month’s event will explore policy, people, and profitability, and how pharmacy businesses can transform these factors toward actionable solutions.
In this episode, host Taylor Watterson, PharmD, PhD, provides a deeper look into workplace fatigue and the metrics used to calculate and facilitate it.
Two separate bills were marked up in House committees last week and were officially advanced to potentially move additional PBM reform into law.
The proposed bill would force pharmacy benefit managers to act on the interests of pharmacies rather than their own companies.
From PBM reform and AI to burnout and closures, Tom DePietro, PharmD, addresses the current state of independent pharmacy.
In part 2, Tom DePietro, PharmD, explores emerging topics of interest within community pharmacy, including AI, PBMs, and the industry’s evolving nature.
Between clinical initiatives, educational strategies, and regulatory frameworks, researchers explore PGx services integration.
Advertisement
Advertisement
Trending on Drug Topics
1
PBMs Must Now Disclose Fees to Employer Plans Under Final DOL Rule
2
PBM Audit Practices Under Scrutiny: What the House Inquiry Means for Independent Pharmacies
3
COVID-19 Vaccine Lowers Venous Thromboembolism, Mortality Risk
4
GLP-1s Outperform Metformin in Prediabetes Risk, MACE
5